World7 months ago
First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer
A recent British Journal of Cancer evaluated the real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer (mTNBC). Study: Real world study of sacituzumab govitecan...
